Document is current
Any future updates will be listed below
-
Authors
Tse, Chung Sang https://orcid.org/0000-0002-8847-4539
Nguyen, Hang P.
Singh, Siddharth
Dulai, Parambir S.
Neill, Jennifer
Le, Helen
Valasek, Mark
Dervieux, Thierry
Collins, Angelina E.
Boland, Brigid Sweeney
-
Funding
Funding for this research was provided by:
American Gastroenterological Association (AGA2022-21-03)
- License Information
-
More Information
Article History
Received: 13 February 2023
Accepted: 22 May 2023
First Online: 3 June 2023
Declarations
:
: CST has received research grants from the American Gastroenterological Association and the Crohn’s and Colitis Foundation. SS has received research grants from AbbVie, Janssen, and Pfizer, and personal fees from Pfizer (for ad hoc grant review). BSB has received research grants from Prometheus Biosciences, Gilead, and has served as a consultant for Bristol Myers Squibb, Pfizer, and Takeda. AEC has received consulting fees from AbbVie, Bristol Myers Squibb, Janssen, and Takeda. TD is an employee at Prometheus Laboratories. PSD has received research support and consultation funding from Takeda, AbbVie, Janssen, Pfizer, and Gilead. JN and HL have no conflicts of interest to declare.
: This human research study was performed in accordance with the Declaration of Helsinki and received Institutional Review Board approval from the University of California, San Diego. All patients provided informed consent.
